Serum MIC-1 concentrations were found to be four times higher in prostate cancer patients with cachexia compared to those without cachexia [58], and its expression was positively associated with the expression of the pro-tumorigenic M2 macrophages in prostate tumours [59]. This evidence concerns the gene GDF15 and Cachexia.